Role of MRSA strains in the pathogenesis of severe atopic dermatitis in childhood. The ways of remission achievement


This article presents results of examination of 63 patients with atopic dermatitis (AD) aged 3 to 18 years. It was demonstrated, that in 87.3% of cases their skin was contaminated by Staphylococcus aureus. In 58.2% of cases pathogenic strains of methicillin-resistant Staphylococcus aureus (MRSA) were detected. Direct correlation between the frequency of MRSA detection and severity of the disease (r = 0,68) as well as age of children (r = 0,58) was revealed. Authors revealed high frequency of multidrug-resistant strains to a variety of antibiotics, except mupirocin, vancomycin, clindamycin, and ciprofloxacin (in the total group of MRSA the prevalence of resistant strains to these antibiotics ranged from 2% in mupirocin to 18% in ciprofloxacin, depending on the severity of AD). Algorithm of the effective combined therapy with mupirocin containing topical drugs (Supirocin ointment, Supirocin B ointment) is presented. This algorithm allowed to achieve stable clinical remission in 100% of cases.

Full Text

Роль метициллинрезистентных штаммов золотистого стафилококка в патогенезе тяжелых форм атопического дерматита в детском возрасте. Пути достижения ремиссии


  1. Мокроносова М. А. Влияние Staphylococcus aureus на течение атопического дерматита. Аллергология, 2003; 1: 46—50.
  2. Giampaolo R. Frequency and Clinical Role of Staphylococcus aureus Overinfection in Atopic Dermatitis in Children. Pediatric Dermatology 2003; 20; 5: 389—392.
  3. Короткий Н.Г. Атопический дерматит у детей. Тверь: Руководство для врачей; 2003: 35—39.
  4. Shuichi H. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. International Journal of Dermatology 1999; 38: 265—269.
  5. Lomholt H. Staphylococcus aureus Clonal Dynamics and Virulence Factors in Children with Atopic Dermatitis. J. Invest. Dermatol 2005; 125: 977—982.
  6. Leung A.D. Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus. Clinical and Experimental Allergy 2006; 38: 789—793.
  7. Morishita Y. Possible influences of Staphylococcus aureus on atopic dermatitis — the colonizing features and the effects of staphylococcal enterotoxins. Clinical and Experimental Allergy 1999; 29: 1110—1117.
  8. Guzik T. J. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clinical and Experimental Allergy 2005; 35: 448—455.
  9. Смолкин Ю.С. Атопический дерматит и иммунный ответ на суперантигены Staphylococcus aureus.
  10. Страчунский Л.С., Белькова Ю.А., Дехнич А.В. Внебольничные MRSA-новая проблема антибиотикорезистентности. Клиническая микробиология и антимикробная химиотерапия, 2005; 7 (1): 32—42.
  11. Suh L. Methicillin-Resistant Staphylococcus aureus Colonization in Children with Atopic Dermaitis. Pediatric Dermatology 2008; 25 (5): 528—534.
  12. Фассахов P.C. Антибиотикорезистентность Staphylococcus aureus, колонизирующего кожу и кишечник у больных атопическим дерматитом. Практическая медицина, 2009; 3: 32—35.
  13. Hon K.L. Atopic dermatitis complicated by methicillin-resistant Staphylococcus aureus infection. J. Natl.Med. Assoc 2008; 100 (7): 797—800.
  14. Карпов И.А. Внебольничные инфекции, обусловленные метициллинрезистентным стафилококком (MRSA): подходы к антибактериальной терапии. Медицинские новости, 2006; 10: 28—32.
  15. Страчунский Л.С. Практическое руководство по антиинфекционной химиотерапии. — М., 2002: 115—116.
  16. Кубанова А.А. (ред.) Атопический дерматит. (Клинические рекомендации. Российское общество дерматовенерологов). М: ДЭКС-Пресс 2010; 39.
  17. Leyden J.The case for steroid-аntibiotic combinations. Br. J. Dermatol 1977; 96: 179—187.
  18. Hauk P. J. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens. J. Allergy Clin.Immunol 2000; 105: 782—787.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies